Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 427,792 | 377,047 | 263,269 | 222,054 | 192,135 |
| Depreciation Amortization | 88,011 | 83,178 | 83,140 | 79,061 | 70,388 |
| Income taxes - deferred | 6,162 | 1,209 | -7,918 | 20,881 | 5,143 |
| Accounts receivable | -22,472 | -18,401 | -24,918 | -22,554 | -50,142 |
| Accounts payable and accrued liabilities | 1,957 | -166 | 1,391 | 2,117 | -2,468 |
| Other Working Capital | -104,969 | -91,640 | 8,380 | 7,374 | -64,373 |
| Other Operating Activity | 62,677 | 48,857 | 49,932 | 30,010 | 71,119 |
| Operating Cash Flow | $459,158 | $400,084 | $373,276 | $338,943 | $221,802 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 284,038 | -47,405 | -24,035 | -215,183 |
| PPE Investments | -154,969 | -115,751 | -74,384 | -64,787 | -82,921 |
| Net Acquisitions | -50,304 | -22,500 | -14,579 | -1,964 | -10,302 |
| Purchase Sale Intangibles | -255 | -7,185 | -2,320 | N/A | 0 |
| Other Investing Activity | -255 | -7,185 | -2,320 | 0 | 0 |
| Investing Cash Flow | $-205,528 | $138,602 | $-138,688 | $-90,786 | $-308,406 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -110,275 | N/A | 44,000 | 38,000 | 24,000 |
| Debt Issued | 100,000 | N/A | N/A | N/A | 250,097 |
| Common Stock Issued | 36,106 | 38,201 | 38,622 | 38,344 | 22,397 |
| Common Stock Repurchased | -309,711 | -378,694 | -290,638 | -308,458 | -407,419 |
| Other Financing Activity | -2,529 | -257,306 | 0 | 9,918 | 9,935 |
| Financing Cash Flow | $-286,409 | $-597,799 | $-208,016 | $-222,196 | $-100,990 |
| Exchange Rate Effect | -689 | -4,768 | 6,202 | -54 | -5,948 |
| Beginning Cash Position | 123,794 | 187,675 | 154,901 | 128,994 | 322,536 |
| End Cash Position | 90,326 | 123,794 | 187,675 | 154,901 | 128,994 |
| Net Cash Flow | $-33,468 | $-63,881 | $32,774 | $25,907 | $-193,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | 459,158 | 400,084 | 373,276 | 338,943 | 221,802 |
| Capital Expenditure | -154,969 | -115,751 | -74,384 | -64,787 | -82,921 |
| Free Cash Flow | 304,189 | 284,333 | 298,892 | 274,156 | 138,881 |